rbcg expressing Brucella melis p39 gene and its construction method and application
A technology for brucellosis and brucellosis, applied in the field of rBCG expressing the P39 gene of brucella melis and its construction, to achieve cost-saving effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1 Construction of recombinant expression vector carrying the gene of Brucella spp. P39
[0031] Include the following steps:
[0032] 1. According to the published sequence of the P39 gene of Brucella spp. M5 strain (GenBank: EF189139.1), after using Jcat software to optimize the codons, artificially synthesize the optimized P39 gene with the full sequence as the target gene (nucleotides). The sequence is shown in SEQ ID NO: 1).
[0033] 2. Construction of the recombinant expression vector carrying the optimized M5 strain P39 gene:
[0034] The above target gene was inserted into the shuttle expression vector pMV361 through the two restriction sites of PvuII and EcoRI.
[0035] 3. Verification of inserting the correct recombinant expression vector:
[0036] Through the determination of nucleic acid sequence, it was confirmed that the recombinant expression vector carrying the optimized Brucella species P39 gene was successfully constructed.
Embodiment 2
[0037] Example 2 Construction of rBCG expressing the P39 gene of Brucella species
[0038] 1. Using BCG as a host strain, transform the recombinant expression vector constructed in Example 1 (full sequence shown in SEQ ID NO: 2) into BCG.
[0039] The electroconversion method was used for conversion. The experimental conditions were: 2500V, 25μF, 1000Ω, electroconversion time 5ms, and 0.1cm electroporation cup. The electrotransformation reaction system is: plasmid 3 μl (concentration is 0.65 μg / μl), competent BCG bacterial solution 100 μl (concentration is about 1×10 10 CFU / ml).
[0040] 2. Screening of positive clones
[0041] After electroporation, pipette the bacterial solution and inoculate it on the medium (slope) containing 50 μg / ml kanamycin to screen for positive clones.
[0042] 3. Detection of target gene expression
[0043] The screened positive clones (ie, recombinant BCG) were inoculated into liquid medium for expansion and culture, the culture supernatant was...
Embodiment 3
[0044] The effect experiment of embodiment 3 brucellosis vaccine
[0045] 6-8 week old female Balb / c mice were immunized with recombinant BCG and injected subcutaneously at a dose of 4 × 10 8 CFU / mouse, 4 weeks after immunization, the expression of Th1 / Th2 cytokines in the serum of mice in each group was detected. The experimental results showed that compared with the recombinant BCG (rBCG-P39(wild)) carrying the unoptimized P39 gene and the untransformed BCG, the recombinant BCG (rBCG-P39) carrying the codon-optimized P39 gene could effectively induce Production of Th1-type cytokines such as IL-2, IL-12 and IFN-γ. ( figure 2 )
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com